Anthem price target raised to $345 from $323 at Jefferies

Jefferies analyst David Windley raised his price target for Anthem to $345 and reiterates a Buy rating on the shares. The analyst says he’s more positive on Anthem’s long-term outlook following meetings with management at the company’s headquarters. Anthem has “numerous levers” to accelerate sales and improve margins, Windley tells investors in a research note. He sees “wide optionality” for management from the $3.2B in pharmacy benefit manager savings they plan to reinvest.
https://thefly.com/landingPageNews.php?id=2831149